$MDLZ
Mondelez International, Inc.

2023 Q4 Form 10-Q Financial Statement

#000110398223000075 Filed on November 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $9.314B $9.029B
YoY Change 7.12% 16.31%
Cost Of Revenue $5.844B $5.535B
YoY Change 3.99% 7.48%
Gross Profit $3.470B $3.494B
YoY Change 12.85% 33.72%
Gross Profit Margin 37.26% 38.7%
Selling, General & Admin $2.221B $2.019B
YoY Change 4.81% 7.17%
% of Gross Profit 64.01% 57.78%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $313.0M $309.0M
YoY Change 8.68% 14.02%
% of Gross Profit 9.02% 8.84%
Operating Expenses $2.258B $2.019B
YoY Change 4.78% 7.17%
Operating Profit $1.212B $1.379B
YoY Change 31.74% 103.09%
Interest Expense -$118.0M -$135.0M
YoY Change 37.21% 18.42%
% of Operating Profit -9.74% -9.79%
Other Income/Expense, Net $88.00M -$66.00M
YoY Change 266.67% -7.04%
Pretax Income $1.163B $1.331B
YoY Change 50.65% 108.62%
Income Tax $257.0M $354.0M
% Of Pretax Income 22.1% 26.6%
Net Earnings $950.0M $984.0M
YoY Change 62.95% 84.96%
Net Earnings / Revenue 10.2% 10.9%
Basic Earnings Per Share $0.72
Diluted Earnings Per Share $0.70 $0.72
COMMON SHARES
Basic Shares Outstanding 1.361B shares 1.360B shares
Diluted Shares Outstanding 1.370B shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.810B $1.610B
YoY Change -5.88% -26.05%
Cash & Equivalents $1.884B $1.677B
Short-Term Investments $0.00
Other Short-Term Assets $1.766B $1.806B
YoY Change 100.68% 115.77%
Inventory $3.615B $3.808B
Prepaid Expenses
Receivables $3.634B $3.498B
Other Receivables $878.0M $793.0M
Total Short-Term Assets $11.70B $11.52B
YoY Change 15.97% 16.2%
LONG-TERM ASSETS
Property, Plant & Equipment $10.38B $9.750B
YoY Change 7.2% 4.84%
Goodwill $23.90B $23.31B
YoY Change 1.9% 4.11%
Intangibles $19.84B $19.48B
YoY Change 0.64% 0.84%
Long-Term Investments $3.242B $3.100B
YoY Change -33.55% -31.11%
Other Assets $886.0M $2.173B
YoY Change -52.42% 103.46%
Total Long-Term Assets $59.69B $59.35B
YoY Change -2.26% 2.1%
TOTAL ASSETS
Total Short-Term Assets $11.70B $11.52B
Total Long-Term Assets $59.69B $59.35B
Total Assets $71.39B $70.86B
YoY Change 0.32% 4.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.321B $7.658B
YoY Change 10.04% 13.86%
Accrued Expenses $3.841B $3.747B
YoY Change 15.73% 21.38%
Deferred Revenue
YoY Change
Short-Term Debt $420.0M $1.221B
YoY Change -81.73% -30.35%
Long-Term Debt Due $2.101B $2.354B
YoY Change 448.56% 2254.0%
Total Short-Term Liabilities $19.01B $18.94B
YoY Change 13.64% 32.23%
LONG-TERM LIABILITIES
Long-Term Debt $16.89B $16.41B
YoY Change -16.61% -17.16%
Other Long-Term Liabilities $2.735B $2.479B
YoY Change 1.75% -0.12%
Total Long-Term Liabilities $2.735B $2.479B
YoY Change 1.75% -0.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.01B $18.94B
Total Long-Term Liabilities $2.735B $2.479B
Total Liabilities $43.03B $42.30B
YoY Change -2.75% 2.26%
SHAREHOLDERS EQUITY
Retained Earnings $34.24B $33.87B
YoY Change 8.75% 7.73%
Common Stock $32.22B $32.18B
YoY Change 0.23% 0.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.33B $28.54B
YoY Change
Total Liabilities & Shareholders Equity $71.39B $70.86B
YoY Change 0.32% 4.15%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $950.0M $984.0M
YoY Change 62.95% 84.96%
Depreciation, Depletion And Amortization $313.0M $309.0M
YoY Change 8.68% 14.02%
Cash From Operating Activities $1.564B $1.177B
YoY Change 12.36% 114.39%
INVESTING ACTIVITIES
Capital Expenditures $332.0M $285.0M
YoY Change -216.49% -220.76%
Acquisitions
YoY Change
Other Investing Activities $1.358B $821.0M
YoY Change -213.83% -137.75%
Cash From Investing Activities $1.026B $536.0M
YoY Change -169.42% -122.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.484B -1.535B
YoY Change 1462.26% -169.18%
NET CHANGE
Cash From Operating Activities 1.564B 1.177B
Cash From Investing Activities 1.026B 536.0M
Cash From Financing Activities -2.484B -1.535B
Net Change In Cash 106.0M 178.0M
YoY Change -143.27% -50.14%
FREE CASH FLOW
Cash From Operating Activities $1.564B $1.177B
Capital Expenditures $332.0M $285.0M
Free Cash Flow $1.232B $892.0M
YoY Change -26.54% 13.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28560000000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70860000000 usd
CY2023Q3 mdlz Dividends Paid On Noncontrolling Interest And Other Activities
DividendsPaidOnNoncontrollingInterestAndOtherActivities
5000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28560000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26920000000 usd
us-gaap Profit Loss
ProfitLoss
4018000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-297000000 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
209000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
662000000 usd
us-gaap Dividends Cash
DividendsCash
1633000000 usd
mdlz Dividends Paid On Noncontrolling Interest And Other Activities
DividendsPaidOnNoncontrollingInterestAndOtherActivities
-5000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28560000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27553000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
533000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-605000000 usd
CY2022Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
53000000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
338000000 usd
CY2022Q3 us-gaap Dividends Cash
DividendsCash
524000000 usd
us-gaap Profit Loss
ProfitLoss
2142000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
819000000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-38000000 usd
mdlz Equity Method Investment Realized Gain Loss On Transaction
EquityMethodInvestmentRealizedGainLossOnTransaction
-19000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
300000000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
169000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-32000000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
625000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
745000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
332000000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
143000000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
413000000 usd
mdlz Increase Decrease In Pension Assets And Obligations And Postretirement Obligations
IncreaseDecreaseInPensionAssetsAndObligationsAndPostretirementObligations
162000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2516000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
621000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3978000000 usd
mdlz Proceeds From Sale Of Equity Method Investments And Divestiture Of Businesses Net Of Cash Divested
ProceedsFromSaleOfEquityMethodInvestmentsAndDivestitureOfBusinessesNetOfCashDivested
604000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-585000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3410000000 usd
us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
0 usd
mdlz Proceeds From Repayments Of Other Short Term Debt
ProceedsFromRepaymentsOfOtherShortTermDebt
-1070000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
189000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2087000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
659000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
134000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5074000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-133000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-271000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1948000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
135000000 usd
CY2023Q3 us-gaap Supplier Finance Program Obligation
SupplierFinanceProgramObligation
2300000000 usd
CY2022Q4 us-gaap Supplier Finance Program Obligation
SupplierFinanceProgramObligation
2400000000 usd
CY2023Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1996537778 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1996537778 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32181000000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32143000000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
33866000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
31481000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11232000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10947000000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
635672022 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
630646687 shares
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
26280000000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
25794000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
28535000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
26883000000 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
25000000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
37000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26920000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71161000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28679000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
988000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-528000000 usd
CY2023Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
63000000 usd
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
57000000 usd
CY2023Q3 us-gaap Dividends Cash
DividendsCash
580000000 usd
CY2022Q3 mdlz Dividends Paid On Noncontrolling Interest And Other Activities
DividendsPaidOnNoncontrollingInterestAndOtherActivities
2000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26670000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28323000000 usd
us-gaap Profit Loss
ProfitLoss
2142000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-634000000 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
178000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1843000000 usd
us-gaap Dividends Cash
DividendsCash
1493000000 usd
mdlz Dividends Paid On Noncontrolling Interest And Other Activities
DividendsPaidOnNoncontrollingInterestAndOtherActivities
3000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26670000000 usd
us-gaap Profit Loss
ProfitLoss
4018000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
902000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
109000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
88000000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9000000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
41000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
95000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
178000000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 usd
mdlz Equity Method Investment Realized Gain Loss On Transaction
EquityMethodInvestmentRealizedGainLossOnTransaction
465000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
116000000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
136000000 usd
us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
259000000 usd
us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-220000000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
593000000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-53000000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
687000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
484000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
18000000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
108000000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
641000000 usd
mdlz Increase Decrease In Pension Assets And Obligations And Postretirement Obligations
IncreaseDecreaseInPensionAssetsAndObligationsAndPostretirementObligations
120000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3150000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
780000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-19000000 usd
mdlz Proceeds From Sale Of Equity Method Investments And Divestiture Of Businesses Net Of Cash Divested
ProceedsFromSaleOfEquityMethodInvestmentsAndDivestitureOfBusinessesNetOfCashDivested
2727000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
180000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1786000000 usd
us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
67000000 usd
us-gaap Repayments Of Commercial Paper
RepaymentsOfCommercialPaper
67000000 usd
us-gaap Repayments Of Commercial Paper
RepaymentsOfCommercialPaper
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
1581000000 usd
CY2022Q4 mdlz Accounts Receivable Sold Under Factoring Program Principal Amount Outstanding
AccountsReceivableSoldUnderFactoringProgramPrincipalAmountOutstanding
516000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
86000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
101000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
206000000 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1027000000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1031000000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2924000000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2501000000 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
3951000000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
3532000000 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
143000000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
151000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3808000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
3381000000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
16773000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
16231000000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
7631000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
7211000000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9142000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9020000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
780000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
321000000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
324000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
621000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
255000000 usd
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
249000000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
21978000000 usd
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-757000000 usd
CY2022 mdlz Goodwill Acquired During Period Net Of Adjustment
GoodwillAcquiredDuringPeriodNetOfAdjustment
2529000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
23450000000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-113000000 usd
mdlz Goodwill Acquired During Period Net Of Adjustment
GoodwillAcquiredDuringPeriodNetOfAdjustment
-30000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
23307000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3259000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2071000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1188000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3354000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2057000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1297000000 usd
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
18287000000 usd
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
18287000000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
18413000000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
18413000000 usd
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
21546000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2071000000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19475000000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
21767000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2057000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19710000000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
114000000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
96000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
145000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
145000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
145000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
95000000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
90000000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
3100000000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
4900000000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10000000 usd
CY2023Q3 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
34000000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
85000000 usd
CY2022Q3 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
48000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
116000000 usd
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
136000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
300000000 usd
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
169000000 usd
CY2023Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
1221000000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
2299000000 usd
CY2023Q3 mdlz Debt Instrument Reclassification Of Long Term Debt To Short Term Debt Amount
DebtInstrumentReclassificationOfLongTermDebtToShortTermDebtAmount
2000000000.0 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
134000000 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
114000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
432000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
294000000 usd
CY2023Q3 mdlz Gains Losses On Extinguishment Of Debt And Related Expenses
GainsLossesOnExtinguishmentOfDebtAndRelatedExpenses
0 usd
CY2022Q3 mdlz Gains Losses On Extinguishment Of Debt And Related Expenses
GainsLossesOnExtinguishmentOfDebtAndRelatedExpenses
0 usd
mdlz Gains Losses On Extinguishment Of Debt And Related Expenses
GainsLossesOnExtinguishmentOfDebtAndRelatedExpenses
-1000000 usd
mdlz Gains Losses On Extinguishment Of Debt And Related Expenses
GainsLossesOnExtinguishmentOfDebtAndRelatedExpenses
-129000000 usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
68000000 usd
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
43000000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
175000000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
86000000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-66000000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-71000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-258000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-337000000 usd
CY2023Q3 us-gaap Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement
DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
1647000000 usd
CY2023Q3 us-gaap Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement
DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
1172000000 usd
CY2022Q4 us-gaap Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement
DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
790000000 usd
CY2022Q4 us-gaap Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement
DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
629000000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
475000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
161000000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
602000000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
642000000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
20490250 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.31
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
417000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2459340 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
65.37
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3457739 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
39.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
110000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
270017 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
57.52
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19221834 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.82
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
376000000 usd
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
29000000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
134000000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
2000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
19000000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
4451674 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
60.12
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2202361 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
66.79
mdlz Weighted Average Grant Date Fair Value Stock Granted
WeightedAverageGrantDateFairValueStockGranted
147000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1658391 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
62.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
104000000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
247953 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
62.58
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
4747691 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
62.18
CY2023Q3 mdlz Share Based Compensation Tax Benefit Realized From Stock Awards Vesting
ShareBasedCompensationTaxBenefitRealizedFromStockAwardsVesting
0 usd
mdlz Share Based Compensation Tax Benefit Realized From Stock Awards Vesting
ShareBasedCompensationTaxBenefitRealizedFromStockAwardsVesting
2000000 usd
CY2023Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
35000000 usd
CY2022Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
103000000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-6000000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
143000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-528000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-605000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-297000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-634000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-6000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-12000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-12000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-27000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-522000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-593000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-285000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-607000000 usd
CY2023Q3 mdlz Estimated Annual Effective Tax Rate From Continuing Operations
EstimatedAnnualEffectiveTaxRateFromContinuingOperations
0.259
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.266
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.271
mdlz Effective Income Tax Rate Reconciliation Excluding Effect Of Sale Of Equity Securities
EffectiveIncomeTaxRateReconciliationExcludingEffectOfSaleOfEquitySecurities
0.244
mdlz Effective Income Tax Rate Reconciliation Excluding Effect Of Sale Of Equity Securities
EffectiveIncomeTaxRateReconciliationExcludingEffectOfSaleOfEquitySecurities
0.244
CY2022Q3 mdlz Estimated Annual Effective Tax Rate From Continuing Operations
EstimatedAnnualEffectiveTaxRateFromContinuingOperations
0.240
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.288
CY2022Q3 mdlz Effective Income Tax Rate Reconciliation Excluding Impact From Employee Stock Ownership Plan Percent
EffectiveIncomeTaxRateReconciliationExcludingImpactFromEmployeeStockOwnershipPlanPercent
0.199
CY2022Q3 mdlz Effective Tax Rate Net Tax Expense Benefit
EffectiveTaxRateNetTaxExpenseBenefit
-28000000 usd
CY2022Q3 mdlz Income Tax Reconciliation Tax Settlements And Expiration Of Statute Of Limitations Expense Benefit
IncomeTaxReconciliationTaxSettlementsAndExpirationOfStatuteOfLimitationsExpenseBenefit
-43000000 usd
CY2022Q3 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
13000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242
mdlz Effective Tax Rate Net Tax Expense Benefit
EffectiveTaxRateNetTaxExpenseBenefit
-92000000 usd
mdlz Income Tax Reconciliation Tax Settlements And Expiration Of Statute Of Limitations Expense Benefit
IncomeTaxReconciliationTaxSettlementsAndExpirationOfStatuteOfLimitationsExpenseBenefit
-75000000 usd
mdlz Income Tax Reconciliation Business Combination
IncomeTaxReconciliationBusinessCombination
-43000000 usd
us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
22000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
988000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
533000000 usd
us-gaap Profit Loss
ProfitLoss
4018000000 usd
us-gaap Profit Loss
ProfitLoss
2142000000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4000000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
984000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
532000000 usd
us-gaap Net Income Loss
NetIncomeLoss
4009000000 usd
us-gaap Net Income Loss
NetIncomeLoss
2134000000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1363000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1372000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1364000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1381000000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1370000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1379000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1372000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1389000000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.94
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.55
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.54
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 segment
CY2023Q3 us-gaap Revenues
Revenues
9029000000 usd
CY2022Q3 us-gaap Revenues
Revenues
7763000000 usd
us-gaap Revenues
Revenues
26702000000 usd
us-gaap Revenues
Revenues
22801000000 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
19000000 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-186000000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
239000000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-268000000 usd
CY2023Q3 mdlz Segment Reporting General Corporate Expenses
SegmentReportingGeneralCorporateExpenses
86000000 usd
CY2022Q3 mdlz Segment Reporting General Corporate Expenses
SegmentReportingGeneralCorporateExpenses
58000000 usd
mdlz Segment Reporting General Corporate Expenses
SegmentReportingGeneralCorporateExpenses
242000000 usd
mdlz Segment Reporting General Corporate Expenses
SegmentReportingGeneralCorporateExpenses
170000000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38000000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
114000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
96000000 usd
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2022Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
292000000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
318000000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1379000000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
679000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
4309000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2700000000 usd
CY2023Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-19000000 usd
CY2022Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-30000000 usd
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-60000000 usd
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-93000000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-66000000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-71000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-258000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-337000000 usd
CY2023Q3 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-1000000 usd
CY2022Q3 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
0 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
606000000 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
0 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1331000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
638000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4717000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2456000000 usd
CY2023Q3 us-gaap Revenues
Revenues
9029000000 usd
CY2022Q3 us-gaap Revenues
Revenues
7763000000 usd
us-gaap Revenues
Revenues
26702000000 usd
us-gaap Revenues
Revenues
22801000000 usd
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001103982-23-000075-index-headers.html Edgar Link pending
0001103982-23-000075-index.html Edgar Link pending
0001103982-23-000075.txt Edgar Link pending
0001103982-23-000075-xbrl.zip Edgar Link pending
ex311_93023.htm Edgar Link pending
ex312_93023.htm Edgar Link pending
ex321_93023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mdlz-20230930.htm Edgar Link pending
mdlz-20230930.xsd Edgar Link pending
mdlz-20230930_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
mdlz-20230930_lab.xml Edgar Link unprocessable
mdlz-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
mdlz-20230930_cal.xml Edgar Link unprocessable
mdlz-20230930_pre.xml Edgar Link unprocessable
mdlz-20230930_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending